RC

Ramesh Chander Sachdeva

Active Director Additional Director DIN 11023200
DIN 11023200 First appointment Mar 2025 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Chander Sachdeva

Data last updated:

Ramesh Chander Sachdeva is an Additional Director at Sisyphus Biotech Private Limited (since 2025). The company operates in Professional Services.

DIN 11023200
Primary Designation Additional Director
Industry Professional Services
First Appointment 27 Mar 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sisyphus Biotech Private Limited U72100DL2024PTC432503
Additional Director27 Mar 20252024Active

Board colleagues of Ramesh Chander Sachdeva

Directorship timeline

Open interactive timeline →
Sisyphus Biotech Private Limited
Premium access

Shareholding and investment profile for Ramesh Chander Sachdeva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Chander Sachdeva

Ramesh Chander Sachdeva currently holds 1 directorship: Sisyphus Biotech Private Limited (Additional Director, since 27 Mar 2025).

Ramesh Chander Sachdeva was first appointed on 27 Mar 2025 as Additional Director at Sisyphus Biotech Private Limited.

The current boards of Ramesh Chander Sachdeva's companies include Anand Ranganathan (Sisyphus Biotech Private Limited), Shailja Singh (Sisyphus Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available